67. 多発性嚢胞腎 Polycystic kidney disease Clinical trials / Disease details

臨床試験数 : 221 / 薬物数 : 212 - (DrugBank : 55) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 151

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02933268 (ClinicalTrials.gov)	September 26, 2016	18/9/2016	High Water Intake in Polycystic Kidney Disease	Determining Feasibility of Randomisation to High vs ad Libitum WaterIntake in Polycystic Kidney Dise ...	Autosomal Dominant Polycystic Kidney Disease	Dietary Supplement: High water intake;Other: Ad libitum water intake	Cambridge University Hospitals NHS Foundation Trust	PKD Charity;Addenbrookes Charitable Trust;British Renal Society & British Kidney Patient Association ...	Completed	16 Years	N/A	All	42	N/A	United Kingdom
2	NCT02527863 (ClinicalTrials.gov)	February 2015	18/2/2015	Effect of the Aquaretic Tolvaptan on Nitric Oxide System	The Effects of Tolvaptan on Renal Handling of Waterand Sodium, Vasoactive Hormones and Central Hemod ...	Autosomal Dominant Polycystic Kidney Disease	Drug: Tolvaptan;Drug: Placebo	Regional Hospital Holstebro	Aarhus University Hospital	Completed	18 Years	65 Years	All	18	Phase 2	Denmark
3	EUCTR2014-001973-15-DK (EUCTR)	18/11/2014	27/06/2014	The effcts of tolvaptan on renal handling of waterand salt, hormones in the blood at the circulation ...	Renal Handling of Waterand Sodium in Autosomal Dominant Polycystic Kidney Disease.The effects of tol ...	HyponatreamiaSIADH ( Syndrome of Inappropriate Antidiuretic Hormone Secretion) OverhydrationAutosoma ...	Trade Name: Samsca Product Name: Tolvaptan Product Code: C03XA01 INN or Proposed INN: Tolvaptan Other de ...	University Clinic in Nephrology and Hypertension, Department of Medical Research	NULL	Not Recruiting			Female: yes Male: yes			Denmark

First Previous1Next Last